ArticleJournal for immunotherapy of cancer2021

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery.

Jeroen H A Creemers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.